geovax Archives - Vista Partners LLC | HomeVista Partners LLC

From Lab Bench to Stockpile Shelf: GeoVax’s GEO-MVA Aims for the Big Leagues -( $GOVX $IBB $XBI )

by John F. Heerdink, Jr. March 25, 2026 191Views 0Likes

GeoVax’s (GOVX) latest update on its GEO-MVA program reads less like a small-cap press release and more like a biotech coming-of-age story, with Phase 3 now on the horizon and global health agencies finally circling the dance floor. For investors, the mpox/smallpox…

GeoVax Joins the “Post‑Prasad” Party With a Well‑Timed Signal to Buyers and Bureaucrats -( $GOVX $INO $TNXP $VRTX $IBB $XBI )

by John F. Heerdink, Jr. March 11, 2026 267Views 0Likes

The timing could hardly be better: as controversial FDA leader, Vinay Prasad, exits FDA’s CBER and sentiment tilts back toward innovation, GeoVax Labs (NASDAQ: GOVX) has launched formal outreach around future procurement of its GEO‑MVA mpox/smallpox vaccine. The company is effectively telling…

Cancer Therapy & Broad‑Spectrum Vaccine Protection: GeoVax’s Expanding IP and Pipeline -( $GOVX $IBB $XBI )

by Vista Partners LLC December 17, 2025 444Views 0Likes

GeoVax’s (NASDAQ: GOVX) recent appearance in the British Journal of Haematology increasingly resembles the deliberate, early‑stage build‑out of a meaningful new franchise rather than a one‑off academic mention of a new immunotherapy franchise, now reinforced by fresh patent news from the U.S.…

Tag: geovax

From Lab Bench to Stockpile Shelf: GeoVax’s GEO-MVA Aims for the Big Leagues -( $GOVX $IBB $XBI )

GeoVax Joins the “Post‑Prasad” Party With a Well‑Timed Signal to Buyers and Bureaucrats -( $GOVX $INO $TNXP $VRTX $IBB $XBI )

Cancer Therapy & Broad‑Spectrum Vaccine Protection: GeoVax’s Expanding IP and Pipeline -( $GOVX $IBB $XBI )

Your Guide To Staying Informed In The Markets